| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |